View source for Sandbox:Rahmah Al-Edresi

__NOTOC__
{{Xyz}}
'''For patient information, click [[Xyz (patient information)|here]]'''

{{CMG}}; {{AE}}{{RA}}

{{SK}}Idiopathic thrombocytopenic purpura, Immune thrombocytopenic purpura, Autoimmune thrombocytopenic purpura. 

==[[Xyz overview|Overview]]==

==[[Xyz historical perspective|Historical Perspective]]==

==[[Xyz classification|Classification]]==

==[[Xyz pathophysiology|Pathophysiology]]==

==[[Xyz causes|Causes]]==

==[[Xyz differential diagnosis|Differentiating Xyz from other Diseases]]==

==[[Xyz epidemiology and demographics|Epidemiology and Demographics]]==

==[[Xyz risk factors|Risk Factors]]==

==[[Xyz screening|Screening]]==

==[[Xyz natural history, complications and prognosis|Natural History, Complications and Prognosis]]==

==Diagnosis==
[[Xyz diagnostic study of choice|Diagnostic study of choice]] | [[Xyz history and symptoms|History and Symptoms]] | [[Xyz physical examination|Physical Examination]] | [[Xyz laboratory findings|Laboratory Findings]] | [[Xyz electrocardiogram|Electrocardiogram]] | [[Xyz x ray|X-Ray Findings]] | [[Xyz echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Xyz CT scan|CT-Scan Findings]] | [[Xyz MRI|MRI Findings]] | [[Xyz other imaging findings|Other Imaging Findings]] | [[Xyz other diagnostic studies|Other Diagnostic Studies]]

==Treatment==
[[Xyz medical therapy|Medical Therapy]] | [[Xyz interventions|Interventions]] | [[Xyz surgery|Surgery]] | [[Xyz primary prevention|Primary Prevention]] | [[Xyz secondary prevention|Secondary Prevention]] | [[Xyz cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Xyz future or investigational therapies|Future or Investigational Therapies]]

==Case Studies==
[[Xyz case study one|Case #1]]

[[Category: (name of the system)]]